|
FAM20B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.31829999986344E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.26419999999061E-05 |
| Normal-vs-Stage2 |
3.447800E-04 |
| Normal-vs-Stage3 |
2.32759999996279E-06 |
| Normal-vs-Stage4 |
4.66789999997719E-06 |
| Stage1-vs-Stage2 |
7.525000E-01 |
| Stage1-vs-Stage3 |
3.500000E-01 |
| Stage1-vs-Stage4 |
2.521000E-01 |
| Stage2-vs-Stage3 |
7.222000E-01 |
| Stage2-vs-Stage4 |
5.892400E-01 |
| Stage3-vs-Stage4 |
8.212800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.34070000008025E-07 |
| Normal-vs-AfricanAmerican |
1.814420E-01 |
| Normal-vs-Asian |
6.42049999999283E-05 |
| Caucasian-vs-AfricanAmerican |
5.010100E-02 |
| Caucasian-vs-Asian |
9.394800E-01 |
| AfricanAmerican-vs-Asian |
4.817900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91090000051442E-07 |
| Normal-vs-Female |
4.28929999995997E-06 |
| Male-vs-Female |
2.494000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.802360E-04 |
| Normal-vs-Age(41-60Yrs) |
3.50039999985619E-07 |
| Normal-vs-Age(61-80Yrs) |
1.87783999999747E-05 |
| Normal-vs-Age(81-100Yrs) |
4.945700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.835390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.003400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.860600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.932000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.716200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.646000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.956090E-03 |
| Classical-VS-Follicular |
8.942400E-02 |
| Classical-VS-Other |
7.446400E-02 |
| Classical-VS-Normal |
1.033970E-04 |
| Tall-VS-Follicular |
1.454770E-01 |
| Tall-VS-Other |
5.205400E-01 |
| Tall-VS-Normal |
2.20470000034112E-07 |
| Follicular-VS-Other |
2.624600E-01 |
| Follicular-VS-Normal |
2.2552000000009E-05 |
| Other-VS-Normal |
2.076500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.52360000025421E-07 |
| Normal-vs-N1 |
6.18780000016805E-07 |
| N0-vs-N1 |
3.404000E-01 |
|
|
